highperformr logo

OMEICOS Therapeutics GmbH's Overview

Total employees9
HeadquartersBerlin
Founded2013

Omeicos Therapeutics GmbH is a clinical-stage biopharmaceutical company focused on the discovery and development of novel, first-in-class small molecule therapeutics. These are synthetic analogues of omega-3 fatty acid metabolites, specifically epoxyeicosanoids, designed to be metabolically stable. The company's research targets severe inflammatory, cardiovascular, and ophthalmic diseases, aiming to address significant unmet medical needs with innovative treatments. Omeicos originated as a spin-off from the Max Delbrück Center for Molecular Medicine (MDC) in Berlin.

Where is OMEICOS Therapeutics GmbH's Headquarters?

HQ Function

Serves as the central hub for research and development, clinical trial management, strategic planning, corporate administration, and alliance management.

Notable Features:

Located within the Campus Berlin-Buch, a leading science and biotechnology park, providing access to state-of-the-art laboratory facilities, shared research infrastructure, and a collaborative scientific ecosystem.

Work Culture:

A science-driven, innovative, and collaborative work environment. Employees are typically highly qualified professionals focused on pioneering research and development of novel therapeutics. The culture emphasizes teamwork, scientific rigor, and a commitment to addressing significant medical challenges.

HQ Significance:

The Berlin headquarters is pivotal as the company's main operational and strategic center, driving all R&D activities from discovery through clinical development, and fostering collaborations within the rich Berlin biotech ecosystem.

Values Reflected in HQ: The headquarters' location and facilities reflect Omeicos' commitment to scientific excellence, innovation, collaboration with leading research institutions, and the translation of cutting-edge science into medical treatments.

Location:

Omeicos Therapeutics GmbH, while headquartered in Germany, conducts clinical trials and research collaborations that may span multiple countries, particularly within Europe and North America, to advance its therapeutic pipeline. Its global activities support drug development, regulatory affairs, and preparations for potential future commercialization.

Street Address:

Robert-Roessle-Str. 10, Building D79

City:

Berlin

State/Province:

Berlin

Country:

Germany

OMEICOS Therapeutics GmbH's Global Presence

Buying Intent Signals for OMEICOS Therapeutics GmbH

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of OMEICOS Therapeutics GmbH

As of April 2025, OMEICOS Therapeutics GmbH' leadership includes:

Dr. Robert Fischer - Chief Executive Officer (CEO)
Dr. Ulrike Lemke - Vice President Research & Alliance Management
Prof. Dr. med. univ. Bernd Jilma - Chief Medical Officer (CMO)
Dr. Wolf-Christian Schipper - Head of Clinical Operations

Investors of OMEICOS Therapeutics GmbH

OMEICOS Therapeutics GmbH has been backed by several prominent investors over the years, including:

Forbion Capital Partners
BioMedPartners
Vesalius Biocapital III
Remiges BioPharma Fund
Ascenion GmbH
Kreditanstalt für Wiederaufbau (KfW)
IBB Beteiligungsgesellschaft
The Falck Stifung
Die Brückenköpfe
Various Family Offices

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits1

Dr. Karen Uhlmann, former CFO/CBO, departed from Omeicos Therapeutics in late 2023. Public information on other specific executive hires in the immediate last 12 months is limited.

Departures

Dr. Karen Uhlmann, Dr. Karen Uhlmann concluded her role as CFO/CBO at Omeicos Therapeutics.

Technology (Tech Stack) used by OMEICOS Therapeutics GmbH

Discover the tools OMEICOS Therapeutics GmbH uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

OMEICOS Therapeutics GmbH Email Formats and Examples

Common email formats for Omeicos Therapeutics GmbH likely utilize a combination of the employee's first initial and last name, or full name, with the company domain '@omeicos.com'.

[first_initial].[last]@omeicos.com

Format

r.fischer@omeicos.com

Example

80%

Success rate

News and media

Omeicos Therapeutics WebsiteJanuary 23, 2024

Omeicos Therapeutics GmbH to Present at the Angiogenesis, Exudation, and Degeneration 2024 Conference

Omeicos Therapeutics announced its participation and presentation at the Angiogenesis, Exudation, and Degeneration 2024 conference, showcasing recent advancements in its ophthalmic programs and specifically highlighting data related to OMT-28....more

Omeicos Therapeutics WebsiteJune 27, 2023

Omeicos Therapeutics GmbH Reports Positive Topline Results from Phase 2a CLIOMACS Trial with OMT-28 in Patients with Macular Edema

Omeicos Therapeutics announced positive topline data from its Phase 2a CLIOMACS clinical trial evaluating OMT-28 for the treatment of patients with persistent macular edema due to retinal vein occlusion (RVO) or diabetes (DME). The study met its primary safety and tolerability endpoints, and OMT-28 demonstrated promising efficacy signals, supporting its further clinical development....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including OMEICOS Therapeutics GmbH, are just a search away.